Cargando…

Effect of taurine administration on symptoms, severity, or clinical outcome of dilated cardiomyopathy and heart failure in humans: a systematic review

Background: Taurine, 2-aminoethanesulfonic acid, is an amino acid found in animal products. Taurine is produced for human consumption as a supplement and ingredient in beverages. Supplementation is a safe, inexpensive, and effective treatment for dilated cardiomyopathy (DCM) in domestic mammals, how...

Descripción completa

Detalles Bibliográficos
Autores principales:	McGurk, Kathryn A., Kasapi, Melpomeni, Ware, James S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	F1000 Research Limited 2022
Materias:	Systematic Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9257265/ https://www.ncbi.nlm.nih.gov/pubmed/35855073 http://dx.doi.org/10.12688/wellcomeopenres.17505.3

Ejemplares similares

Taurine deficiency and dilated cardiomyopathy in golden retrievers fed commercial diets
por: Kaplan, Joanna L., et al.
Publicado: (2018)

Correction: Taurine deficiency and dilated cardiomyopathy in golden retrievers fed commercial diets
por: Kaplan, Joanna L., et al.
Publicado: (2018)

Heart failure in dilated non-ischaemic cardiomyopathy
por: Seferović, Petar M, et al.
Publicado: (2019)

Nemaline myopathy with dilated cardiomyopathy and severe heart failure: A case report
por: Wang, Qian, et al.
Publicado: (2021)

Immunoadsorption Therapy for Patients with Dilated Cardiomyopathy and Heart Failure
por: Ikeda, Uichi, et al.
Publicado: (2008)

Genetics and genomics of dilated cardiomyopathy and systolic heart failure
por: Tayal, Upasana, et al.
Publicado: (2017)

Mortality risk in dilated cardiomyopathy: the accuracy of heart failure prognostic models and dilated cardiomyopathy‐tailored prognostic model
por: Dziewięcka, Ewa, et al.
Publicado: (2020)

Survival benefit of ghrelin in the heart failure due to dilated cardiomyopathy
por: Du, Cheng-Kun, et al.
Publicado: (2014)

Maintaining Success for Patients With Dilated Cardiomyopathy and Remission of Heart Failure
por: Halliday, Brian P., et al.
Publicado: (2022)

The Role of Cardiac T-Cadherin in the Indicating Heart Failure Severity of Patients with Non-Ischemic Dilated Cardiomyopathy
por: Baltrūnienė, Vaida, et al.
Publicado: (2020)

Cardiac‐Specific Deletion of Orai3 Leads to Severe Dilated Cardiomyopathy and Heart Failure in Mice
por: Gammons, Jesse, et al.
Publicado: (2021)

Peripartum cardiomyopathy and dilated cardiomyopathy: different at heart
por: Bollen, Ilse A. E., et al.
Publicado: (2015)

Enalapril and Enalaprilat Pharmacokinetics in Children with Heart Failure Due to Dilated Cardiomyopathy and Congestive Heart Failure after Administration of an Orodispersible Enalapril Minitablet (LENA-Studies)
por: Laeer, Stephanie, et al.
Publicado: (2022)

Prevalence of Anemia in Children with Congestive Heart Failure due to Dilated Cardiomyopathy
por: Mueller, Goetz Christoph, et al.
Publicado: (2012)

Induction of Ankrd1 in Dilated Cardiomyopathy Correlates with the Heart Failure Progression
por: Bogomolovas, Julius, et al.
Publicado: (2015)

Myocarditis in Paediatric Patients: Unveiling the Progression to Dilated Cardiomyopathy and Heart Failure
por: Farinha, Inês Teixeira, et al.
Publicado: (2016)

Metabolomics Fingerprint Predicts Risk of Death in Dilated Cardiomyopathy and Heart Failure
por: Vignoli, Alessia, et al.
Publicado: (2022)

Adrenergic receptor genotype influences heart failure severity and β-blocker response in children with dilated cardiomyopathy
por: Reddy, Sushma, et al.
Publicado: (2015)

Oxidative Stress Markers and C-Reactive Protein Are Related to Severity of Heart Failure in Patients with Dilated Cardiomyopathy
por: Wojciechowska, Celina, et al.
Publicado: (2014)

Development of plasma and whole blood taurine reference ranges and identification of dietary features associated with taurine deficiency and dilated cardiomyopathy in golden retrievers: A prospective, observational study
por: Ontiveros, Eric S., et al.
Publicado: (2020)

Correction: Development of plasma and whole blood taurine reference ranges and identification of dietary features associated with taurine deficiency and dilated cardiomyopathy in golden retrievers: a prospective, observational study
Publicado: (2023)

Silent cerebral infarction in chronic heart failure: Ischemic and nonischemic dilated cardiomyopathy
por: Kozdag, Guliz, et al.
Publicado: (2008)

Bmi1 limits dilated cardiomyopathy and heart failure by inhibiting cardiac senescence
por: Gonzalez-Valdes, I., et al.
Publicado: (2015)

Identification of Potential Gene Interactions in Heart Failure Caused by Idiopathic Dilated Cardiomyopathy
por: Huang, Huijuan, et al.
Publicado: (2018)

Immune-inflammatory concept of the pathogenesis of chronic heart failure in dogs with dilated cardiomyopathy
por: Vatnikov, Yu, et al.
Publicado: (2019)

Choroidal thickness changes in children with chronic heart failure due to dilated cardiomyopathy
por: Rakusiewicz, Klaudia, et al.
Publicado: (2021)

Dilated Cardiomyopathy and Systolic Heart Failure in a Female Patient With Danon Disease
por: Stack-Pyle, Taylor J, et al.
Publicado: (2022)

Rodent Models of Dilated Cardiomyopathy and Heart Failure for Translational Investigations and Therapeutic Discovery
por: Ponzoni, Matteo, et al.
Publicado: (2023)

CMRI morphological and functional changes of the heart in myocarditis and dilated cardiomyopathy in acute pediatric heart failure
por: Kharabish, Ahmed E
Publicado: (2016)

The effect of taurine supplementation on the renin–angiotensin–aldosterone system of dogs with congestive heart failure
por: Brethel, Sara, et al.
Publicado: (2023)

Expression of Concern: Development of plasma and whole blood taurine reference ranges and identification of dietary features associated with taurine deficiency and dilated cardiomyopathy in golden retrievers: A prospective, observational study
Publicado: (2020)

The Effects of Exercise-Based Interventions on Fluid Overload Symptoms in Patients with Heart Failure: A Systematic Review and Meta-Analysis
por: Fu, Mei Rosemary, et al.
Publicado: (2022)

The effect of ivabradine therapy on dilated cardiomyopathy patients with congestive heart failure: a systematic review and meta-analysis
por: Yang, Juntao, et al.
Publicado: (2023)

Inflammation-Related Biomarkers Are Associated with Heart Failure Severity and Poor Clinical Outcomes in Patients with Non-Ischemic Dilated Cardiomyopathy
por: Kažukauskienė, Ieva, et al.
Publicado: (2021)

Usefulness of Running Wheel for Detection of Congestive Heart Failure in Dilated Cardiomyopathy Mouse Model
por: Sugihara, Masami, et al.
Publicado: (2013)

Comparison of myocardial mechanical properties in patients with dilated cardiomyopathy with and without acute heart failure
por: Choudhary, Naila, et al.
Publicado: (2014)

Identification of micro-RNA networks in end-stage heart failure because of dilated cardiomyopathy
por: Zhu, Xiaoming, et al.
Publicado: (2013)

Circulating Omentin-1 Levels Are Decreased in Dilated Cardiomyopathy Patients with Overt Heart Failure
por: Huang, Ying, et al.
Publicado: (2016)

The Role of Serum Adiponectin for Outcome Prediction in Patients with Dilated Cardiomyopathy and Advanced Heart Failure
por: Baltrūnienė, Vaida, et al.
Publicado: (2017)

Enhanced heart failure, mortality and renin activation in female mice with experimental dilated cardiomyopathy
por: Tripathi, Ranjana, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_b3sa8ld37iqeoic65ipjhtsbfm